A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancer
- 31 October 1989
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (10) , 1509-1510
- https://doi.org/10.1016/0277-5379(89)90114-4
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Evaluation of a totally implanted venous access port and portable pump in a continuous chemotherapy infusion schedule on an outpatient basisEuropean Journal of Cancer and Clinical Oncology, 1987
- A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.Journal of Clinical Oncology, 1987
- The role of anthracyclines in the treatment of gastric cancerCancer Treatment Reviews, 1985
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983